Reversal of anticoagulant activity of heparin and low molecular weight heparins by poly-l-lysine: A comparative 'in vitro' study versus protamine sulfate

Thromb Res. 2017 Jul:155:128-130. doi: 10.1016/j.thromres.2017.05.012. Epub 2017 May 12.

Authors

Vandhana Muralidharan-Chari¹, Jaehan Kim¹, Shaker A Mousa²

Affiliations

¹ The Pharmaceutical Research Institute, Albany College of Pharmacy and Health Sciences, Rensselaer, NY, USA.
² The Pharmaceutical Research Institute, Albany College of Pharmacy and Health Sciences, Rensselaer, NY, USA. Electronic address: shaker.mousa@acphs.edu.

PMID: 28538195
DOI: 10.1016/j.thromres.2017.05.012

No abstract available

Publication types

Letter

MeSH terms

Anticoagulants / therapeutic use*
Heparin / adverse effects*
Heparin Antagonists / therapeutic use*
Heparin, Low-Molecular-Weight / adverse effects*
Humans
Lysine
Protamines / pharmacology
Protamines / therapeutic use*

Substances

Anticoagulants
Heparin Antagonists
Heparin, Low-Molecular-Weight
Protamines
Heparin
Lysine